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Background: Over the past two decades, initial disease out-
break reports were increasingly based on nontraditional sources
such as news media, online search queries, social media and par-
ticipatory systems. Strategically tapping into these resources can
help speed up detection, reporting and responses to new outbreaks
of emerging infectious diseases allowing earlier interventions.
The EpiCore Project – a joint venture between the Skoll Global
Threats Fund, HealthMap, ProMED-mail, and TEPHINET – seeks to
maximize the advantage of these nontraditional sources by cre-
ating a system for ﬁeld-based veriﬁcation of reports from these
sources. This system creates a cadre of trained health profession-
als from around the world and leverages their expertise to verify
reports they receive in their geographic proximity through innova-
tive surveillance approaches.
Methods & Materials: The EpiCore project developed a
specialized expert-led training that aims to highlight current dis-
ease surveillance challenges, demonstrate innovative surveillance
methods, explain their role in complementing traditional surveil-
lance, introduce different online sources for outbreak surveillance,
and allow the participants to assess challenges in current innova-
tive surveillance approaches before introducing the unique online
platform speciﬁcally developed by the EpiCore project to connect
health professionals to verify outbreak reports.
The EpiCore Project provided the training in two formats, online
– for accepted applicants to the project, and in-person, which was
conducted at 6 TEPHINETConferences, including theGlobal Confer-
ence and the regional conferences in Asia, Africa, the Middle East,
and Latin America over the past two years.
Results: 174 people attended a series of TEPHINET regional
workshops and provided feedback through surveys, interviews,
and focus groups. This feedback helped mold a specialized online
training that was necessary to reach global audiences, and fur-
ther understand the mechanism by which to recruit and engage
participants worldwide. Since the launch in October of 2015, 80%
accepted applicants successfully ﬁnished the online training and
were granted privileges to access the EpiCore platform where they
could start receiving and responding to requests for veriﬁcation of
disease outbreaks.
Conclusion: The EpiCore project’s training and online platform
are developing a cadre of trained health professionals to verify
reports of potential outbreaks from nontraditional sources, com-
plementing traditional surveillance, and contributing to ﬁnding
outbreaks faster.
http://dx.doi.org/10.1016/j.ijid.2016.02.076
Type: Oral Presentation
Final Abstract Number: 14.003
Session:Oral Presentations: Emerging InfectiousDiseases&OneHealth
Date: Thursday, March 3, 2016
Time: 15:45-17:45
Room: G.05-06
Effect of non-steroidal anti-inﬂammatory drugs
(NSAIDS) on bleeding and liver in dengue
infection
A. Wijewickrama1,∗, G. Abeyrathna2, S.
Gunasena3, D. Idampitiya2
1 Infectious Diseases Hospital, Sri Lanka, Colombo,
Sri Lanka
2 Infectious Diseases Hospital, Colombo, Sri Lanka
3 Medical Research Institute, Colombo, Sri Lanka
Background: Many treatment guidelines for Dengue prohibit
using Non-Steroidal Anti-inﬂammatory Drugs (NSAIDS). However,
these are still used either prescribed by general practitioners or
taken ‘over the counter’ by general public, for symptomatic relief.
Side effects of NSAIDs include hepatitis and increased bleeding.
But, there is no study evidence on howNSAIDS affects bleeding and
liver in Dengue infection.
Methods & Materials: A prospective Case Control Study was
conducted to determine the actual effect of NSAIDs on bleeding
and liver in Dengue. All patients admitted to Dengue Management
Unit at the Infectious Diseases Hospital, Colombo for four months
from 1st of July 2014 were included in the study. Dengue infection
was conﬁrmed byNS1 antigen or Dengue speciﬁc IgM antibodies. A
history of NSAID treatment prior to hospital admission was looked
for. These patients were followed up to see the development of
bleeding and/or hepatitis.
Results: Therewere 919 patients with conﬁrmed Dengue infec-
tion with 499 males and 420 females. Age ranged from 12 to 86
years. (mean 31 years.) 57.2% (n=526) had DF; 42.8% (n=393) had
DHF.
6.6% (n=65)were deﬁnitely treatedwithNSAIDs prior to admis-
sion, while 57% (n=577) have not used NSAIDs deﬁnitely; the
rest (35.6%) were not certain. Out of DF patients 28% developed
bleeding in the non-NSAIDS group while 36.7% had bleeding in the
NSAIDS group (<0.05). Among the DHF patients 34% had bleeding
in non-NSAIDS group while 51% had bleeding in the NSAIDS group
(p<0.05).
25.0% of the NSAIDs users and 14.8% of non-NSAIDS users had
ALT above300/L (p <0.05). 3.1%NSAIDSusers andnonon-NSAIDS
users had ALT greater than 1000 /L.
37.5% of NSAID group and 23.8% of non-NSAIDS group had AST
greater than 300 /L. (p <0.05). 6.2% of NSAIDS group and no non-
NSAIDS group had AST greater than 1000 /L.
Conclusion: There is signiﬁcant increase in bleeding and in
liver enzymederangement inDengue patients treatedwithNSAIDS
20 17th International Congress on Infectious Diseases / International Journal of Infectious Diseases 45S (2016) 1–477
compared to those didn’t have NSAIDS. Hence, NSAIDS should not
be used in fever patients when Dengue is a possibility.
http://dx.doi.org/10.1016/j.ijid.2016.02.077
Type: Oral Presentation
Final Abstract Number: 14.004
Session:Oral Presentations: Emerging InfectiousDiseases&OneHealth
Date: Thursday, March 3, 2016
Time: 15:45-17:45
Room: G.05-06
Clinical features and virology of hand foot
mouth disease in Southern Vietnam, July 2013 -
March 2015
V.M.T. Hoang1,∗, T.A. Nguyen2, T.T. Tran2, M.T.
Ha3, V. Do3, V. Ho3, T.H. Nguyen4, K. Truong
Huu4, N. Le5, C. Nguyen Van Vinh6, Q. Phan6, L.
Thwaites2, S. Sabanthan2, T. Le7, H.R. van Doorn8
1 Oxford Clinical Research Unit, Ho Chi Minh City, Ho
Chi Minh City, Viet Nam
2 Oxford Clinical Research Unit, Ho Chi Minh City,
Viet Nam
3 Children’s Hospital 2, Ho Chi Minh, Viet Nam
4 Children’s Hospital 1, ho Chi Minh City, Viet Nam
5 Children’s Hospital 1, Ho Chi Minh, Viet Nam
6 Hospital for Tropical Disease, Ho Chi Minh, Viet
Nam
7 Oxford University Clinical Research Unit, Ho Chi
Minh, Viet Nam
8 Oxford University, Ho Chi Minh City, Viet Nam
Background: In Asia, hand, foot and mouth disease (HFMD) is
associated with large and sometimes severe outbreaks since 1997,
and is caused by enterovirus A (EV-A), in particular EV-A71. Mon-
itoring the pattern of replacement between EV-A serotypes, the
associated clinical proﬁles and pathogen evolution are essential for
understanding the progress of outbreak/epidemics and develop-
ment of intervention strategies.
Methods&Materials: A large prospective studywas conducted
at three referralhospitals in southernVietnamsince July2013:Chil-
dren’s Hospital 1, Children’s Hospital 2 and Hospital for Tropical
Diseases in Ho Chi Minh City. Clinical data, throat and rectal swabs
were collected and analysed using multiplex real-time and nested
RT-PCRs to detect and identify speciﬁc EV serotypes. Selected pos-
itive swabs were then subjected to VP1 or whole-genome deep
sequencing.
Results: Over 18 months, 1350 HFMD patients were enrolled.
The most common detected pathogens included CV-A6 (24%),
EV-A71 (23%), CV-A16 (11%) and CV-A10 (9%), followed by CV-
A2/A4/A12 and EV-Bs. A total of 295 genome sequences were
obtained. B5 (n=156)was the predominant EV-A71 subgenogroup.
Phylogenetic analysis further showed that all CV-A16 (n=25), CV-
A2 (n=7), CV-A5 (n=3), CV-A8 (n=4), CV-A12 (n=10) and CV-A14
(n=1) were closely related to those from China and the region,
while CV-A4 (n=10), CV-A6 (n=26) and CV-A10 (n=43) clustered
with viruses belonging to genogroups collected in other parts of the
world. Two separate introductions were observed for CV-A4.
Clinically, there was no signiﬁcant difference between CV-A6,
CV-A16 and CV-A10 groups. Patients with EV-A71 infection were
older than those with non-EV-A71 infection (21.7 vs. 17.3 months
old, p <0.001). Other differences included myoclonus (21% vs. 13%,
p =0.001), irritability (17% vs. 70%, p <0.001) and location of ery-
thema. There was a trend toward EV-A71 detection and clinical
severity: 23% grade 1, 17% (2A), 39% (2B group 1), 71% (2B group 2),
64% (3) and 67% (4).
Enteroviruses sequence result within 18 months
EV-A71 subgenogroup replacement 2011-2015
Phylogenetic tree of CV-A10
Conclusion: Our study represents the most comprehensive
descriptive HFMD study fromVietnam to date. The analysis of 1350
patients revealed important insights into the epidemic patterns of
this multi-pathogen disease, including pathogen associated phe-
notypes and viral evolution, which are essential for public health
strategies and of clinical signiﬁcance.
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